Skip to main content

NOTICE: Due to a lapse in annual appropriations, most of this website is not being updated. Learn more.

Form submissions will still be accepted but will not receive responses at this time. Sections of this site for programs using non-appropriated funds (such as NVLAP) or those that are excepted from the shutdown (such as CHIPS and NVD) will continue to be updated.

U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Amino Acid-Specific Binder And Selectively Identifying An Amino Acid

Problem

patent description

The invention is recombinant proteins (see attached sequences) which binds to leucine at the N-terminus of peptides/polypeptides/proteins with high affinity and specificity. Compared to the wild-type T. elongatus ClpS2, which served as the starting point for the discovery of the novel sequence, the invention has a significant difference in the binding discrimination for N-terminal leucine vs other N-terminal amino acids (e.g., phenylalanine). The detection of binding activity using these so called NAAB variants indicates an N-terminal leucine with high confidence.

Invention

N-terminal amino acid binding (NAAB) reagents are a tool for parallel, high-throughput proteomics. Afluorescently-labeled NAAB allows immobilized peptides to be identified by their N-terminal residues using single-molecule fluorescent microscopy, which enables novel proteomic analysis, like fluorescence-based next-generationprotein sequence. We have engineered a leucine-targeting NAAB by making multiple mutations in a variant of theN-End Rule adaptor protein ClpS protein from the cyanobacterium Thermosynechococcus elongatus. Our collectionof mutations was discovered by screening a yeast-display library of T. elongatus ClpS2 by fluorescence-assisted cellsorting for variants that displayed higher affinity and specificity for the leucine target.

Created January 30, 2024
Was this page helpful?